Inhibition of Leptin–ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood–Brain Barrier Model
Open Access
- 23 June 2016
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 28 (6)
Abstract
The adipocyte‐derived hormone leptin regulates appetite and energy homeostasis through the activation of leptin receptors (ObR) on hypothalamic neurones; hence, leptin must be transported through the blood–brain barrier (BBB) to reach its target sites in the central nervous system. During obesity, however, leptin BBB transport is decreased, in part precluding leptin as a viable clinical therapy against obesity. Although the short isoform of the ObR (ObRa) has been implicated in the transport of leptin across the BBB as a result of its elevated expression in cerebral microvessels, accumulating evidence indicates that leptin BBB transport is independent of ObRa. In the present study, we employed an ObR‐neutralising antibody (9F8) to directly examine the involvement of endothelial ObR in leptin transport across an in vitro human BBB model composed of the human endothelial cell line hCMEC/D3. Our results indicate that, although leptin transport across the endothelial monolayer was nonparacellular, and energy‐ and endocytosis‐dependent, it was not inhibited by pre‐treatment with 9F8, despite the ability of the latter to recognise hCMEC/D3‐expressed ObR, prevent leptin–ObR binding and inhibit leptin‐induced signal transducer and activator of transcription 3 (STAT‐3) phosphorylation in hCMEC/D3 cells. Furthermore, hCMEC/D3 cells expressed the transporter protein low‐density lipoprotein receptor‐related protein‐2 (LRP‐2), which is capable of binding and endocytosing leptin. In conclusion, our results demonstrate that leptin binding to and signalling through ObR is not required for efficient transport across human endothelial monolayers, indicating that ObR is not the primary leptin transporter at the human BBB, a role which may fall upon LRP‐2. A deeper understanding of leptin BBB transport will help clarify the exact causes for leptin resistance seen in obesity and aid in the development of more efficient BBB‐penetrating leptin analogues.Keywords
Funding Information
- European Research Council (257182)
This publication has 61 references indexed in Scilit:
- Somato-Dendritic Localization and Signaling by Leptin Receptors in Hypothalamic POMC and AgRP NeuronsPLOS ONE, 2013
- Appetite regulation and weight control: the role of gut hormonesNutrition & Diabetes, 2012
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005
- Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistanceFrontiers in Neuroendocrinology, 2003
- Characterizaton of Short Isoforms of the Leptin Receptor in Rat Cerebral Microvessels and of Brain Uptake of Leptin in Mouse Models of ObesityEndocrinology, 2002
- Central nervous system control of food intakeNature, 2000
- Physiological response to long-term peripheral and central leptin infusion in lean and obese miceProceedings of the National Academy of Sciences, 1997
- Diet-induced obese mice develop peripheral, but not central, resistance to leptin.Journal of Clinical Investigation, 1997
- Leptin enters the brain by a saturable system independent of insulinPeptides, 1996
- Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjectsNature Medicine, 1995